Anthem Biosciences IPO

About Anthem Biosciences IPO

Anthem Biosciences IPO is a book-built public offer with a total issue size of ₹3,395.00 crore. The entire offer consists of an offer for sale, with no fresh issue of shares included in the IPO. This means the company will not receive any proceeds from the issue, as all the shares offered are being sold by existing shareholders.

The specific dates for the Anthem Biosciences IPO, including the opening and closing of the subscription period, have not yet been disclosed. Similarly, the price band for the IPO has not been announced. Once finalised, the allotment details will be updated, and investors can expect further clarity on the listing date. 

The IPO will be managed by JM Financial Limited, which is acting as the book-running lead manager. Kfin Technologies Limited has been appointed as the registrar to the issue, responsible for handling the share allotment and refund process.

Investors are advised to review the Draft Red Herring Prospectus (DRHP) of Anthem Biosciences IPO for complete and detailed information about the issue, including risk factors, financials, and other essential disclosures.

Industry Outlook

1. The global pharmaceutical market is set to grow from USD 1,450.6 billion in 2023 to USD 1,955.6 billion by 2028, at a CAGR of 6.2%. The innovator drug segment, which reached USD 737.1 billion in 2023, is projected to hit USD 1,046.2 billion by 2028 at a higher CAGR of 7.3%. 
2. India’s CRDMO sector, one of the fastest-growing globally, is expected to reach USD 14.1 billion by 2028, growing at 14.0% CAGR. This growth surpasses the global average of 9.0% and is driven by regulatory shifts like the US BIOSECURE Act. Anthem Biosciences, as a key player in the CRDMO space, is likely to benefit from this surge by attracting global pharma clients.
3. Innovations like Flow Chemistry and Recombinant DNA are transforming pharmaceutical production. Anthem Biosciences, with expertise in these areas, stands to gain from the industry’s shift toward scalable, eco-friendly, and efficient manufacturing of complex molecules such as peptides and monoclonal antibodies.

Anthem Biosciences IPO Objectives 

Anthem Biosciences Limited will not receive any proceeds from the Offer. All proceeds from the Offer, after deducting related expenses and applicable taxes, will be received by the selling shareholders.

About Anthem Biosciences Limited 

Anthem Biosciences Limited is a technology-focused Contract Research, Development, and Manufacturing Organisation (CRDMO) with integrated operations across drug discovery, development, and commercial manufacturing. 

Recognised as one of India’s few CRDMOs with both NCE (New Chemical Entity) and NBE (New Biological Entity) capabilities, the company serves a global clientele that includes emerging biotech firms and large pharmaceutical companies.

According to industry data, Anthem Biosciences became the fastest Indian CRDMO to reach ₹10,000 million in revenue within just 14 years, achieving this milestone in Fiscal 2021. It also recorded the highest revenue growth among peers in Fiscal 2023–24. 

The company is known for its innovation across modalities such as RNAi, Antibody-Drug Conjugates (ADCs), peptides, lipids, and oligonucleotides. Manufacturing capabilities include custom synthesis, fermentation, flow chemistry, and biotransformation.

Its operations are split between CRDMO services and specialty ingredient manufacturing. The CRDMO arm supports end-to-end drug development, from target identification to commercial production. The specialty ingredients business produces fermentation-based APIs like enzymes and biosimilars, targeting regulated and semi-regulated markets. 

These segments enhance Anthem’s global positioning and revenue potential.

How To Check the Allotment Status of Anthem Biosciences IPO?

Steps to check IPO allotment status on Angel One’s app:

1. Log in to the Angel One app.
2. Go to the IPO Section and then to IPO Orders.
3. Select the individual IPO that you had applied for and check the allotment status.
4. Angel One will notify you of your IPO allotment status via push notification and email.

How To Apply for the Anthem Biosciences IPO Online?

1. Login to Your Angel One Account: Open the Angel One app or website and log in with your credentials.
2. Locate the IPO Section: Navigate to the 'IPO' section on the platform.
3. Select IPO: Find and select the Anthem Biosciences IPO from the list of open IPOs.
4. Enter the Lot Size: Specify the number of lots you want to bid for.
5. Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application.
6. Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN.

Contact Details of Anthem Biosciences IPO 

Registered office: No. 49, F1 & F2, Canara Bank Road Bommasandra Industrial Area, Phase 1, Bommasandra, Bengaluru, Karnataka, 560099

Phone: +91 080 6672 400

E-mail:investors.abl@anthembio.com

Anthem Biosciences IPO Reservation

Anthem Biosciences IPO Lot Size

Anthem Biosciences IPO, the exact lot size, the number of shares in each lot, and the minimum investment amount have not yet been officially announced. These details will be provided closer to the IPO opening date and will help investors know how much they need to invest at a minimum to participate in the IPO.

Anthem Biosciences IPO Promoter Holding

The promoters of the company include Ajay Bhardwaj, Ganesh Sambasivam, K Ravindra Chandrappa and Ishaan Bhardwaj.

Note: Equity dilution will be determined by subtracting the Shareholding Post Issue from the Shareholding Pre Issue.

Key Performance Indicators for Anthem Biosciences IPO

Anthem Biosciences IPO Prospectus

• Anthem Biosciences IPO DRHP

Anthem Biosciences IPO Registrar and Lead Managers

Anthem Biosciences IPO Lead Managers

• Jm Financial Limited

Registrar for Anthem Biosciences IPO

Kfin Technologies Limited

• Contact Number: 04067162222, 04079611000
• Email Address: anthem.ipo@kfintech.com

Anthem Biosciences IPO Registrar